US Patent 12071456 Extended recombinant polypeptides and compositions comprising same
Patent 12071456 was granted and assigned to Amunix Pharmaceuticals, Inc. on August, 2024 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
January 15, 2021
0
Date of Patent
August 27, 2024
0
Patent Applicant
Patent Application Number
17150426
0
Patent Citations
•••
Patent Inventor Names
Jeffrey L. Cleland
0
Benjamin Spink
0
Nathan Geething
0
Wayne To
0
Volker Schellenberger
0
Chia-wei Wang
0
Willem P. Stemmer
0
Joshua Silverman
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 12071456 Extended recombinant polypeptides and compositions comprising same
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
By using this site, you agree to our Terms of Service.